References
- [1] Anastassion X. Psychosis : Causes, Diagnosis and Treatment. New York : Nova Science Publishers. 2012
- [2] Bresee LC, Majmdar SR, Patten SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. In Schizophrenia Research. 2010; 117(1):75-82
- [3] Fossa AA. The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol. 2008,154:1508-1515
- [4] Gintant GA, Gallacher DJ, Pugsley MK. The ‘overly-sensitive’ heart: Sodium channel block and QRS interval prolongation. Br J Pharmacol. 2011,164: 254-259
- [5] Jones M, Campbell G, Patel D, et al. Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics. Cardiovascular Psychiatry and Neurology. 2013, s. 1-13
- [6] Lee SH, Kim HR, Han RX, et al. Cardiovascular risk assessment of atypical antipsychotic drugs in a zebrafish model. J. Appl. Toxicol. 2013; 33(6):466-470
- [7] Moss AJ. The QT interval and torsade de pointes. Drug Saf. 1999, 21(1)
- [8] Pasterbak B, Svanstrom H, Ranthe MF, et al. Atypical Antipsychotics Olanzapine, Quetiapine, and Risperidone and Risk of Acute Major Cardiovascular Events in Young and Middle-Aged Adults: A Nationwide Register-Based Cohort Study in Denmark. CNS Drugs. 2014; 963-973
- [9] Shafti SS, Jahromi P. Olanzapine induced Q-Tc shortening. Ther Adv Psychopharmacol. 2014; 4(6):240-246
- [10] Silvestre JS, O´Neill MF, Prous JR. Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics. J Psychopharmacol. 2014, (28):329-340
- [11] Silvestre JS, Prous JR. Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol. 2007, 29: 457-465
- [12] Taggart P, Sutton P, Chalabi Z, et al. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation. 2003,107:285-289
- [13] Wang J, Liu YS, Zhu WX, et al. Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis. Scientific Reports. 2014